{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA and EMA Provide Guiding Principles for AI in Drug Development",
"url": "https://www.lexblog.com/2026/01/27/fda-and-ema-provide-guiding-principles-for-ai-in-drug-development/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-HWFKFA40",
"url": "https://www.lexblog.com/lib/HWFKFA40/"
},
"datePublished": "2026-01-27T15:29:52-05:00",
"dateModified": "2026-01-27T12:32:12-05:00",
"author": {
"@type": "Person",
"name": "Craig B. Bleifer, Allyson M. Maur, Jessica L. Vaughn, Ph.D., Bryan S. Walsh"
},
"sourceOrganization": {
"@type": "Organization",
"name": "McGuireWoods LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Password Protected",
"about": "Health Care and Life Sciences ยท Technology and AI",
"sourceUrl": "https://www.passwordprotectedlaw.com/?p=6117",
"sourceStability": "may-move"
}